MADISON KAPLAN: Open Payments
NPI 1831953348 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,633 in 52 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $564 · 2025 $1,633
Food & beverage: $1,526Education: $107
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $453 |
| Regeneron Healthcare Solutions, Inc. | 6 | $228 |
| GENZYME CORPORATION | 4 | $208 |
| Galderma Laboratories, L.P. | 5 | $163 |
| PFIZER INC. | 2 | $141 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $128 |
| Novartis Pharmaceuticals Corporation | 5 | $92 |
| Amgen Inc. | 4 | $73 |
| LEO Pharma Inc. | 2 | $43 |
| Incyte Corporation | 2 | $43 |
Products named: SKYRIZI, DUPIXENT, NEMLUVIO, LITFULO, OTEZLA, ADBRY, OPZELURA, ILUMYA.
Industry payments across FL — which companies pay providers there.
